Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Metrics to compare | SBSG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBSGPeersSector | |
---|---|---|---|---|
P/E Ratio | 35.6x | 27.9x | −0.6x | |
PEG Ratio | −1.47 | 0.10 | 0.00 | |
Price/Book | 2.3x | 2.5x | 2.6x | |
Price / LTM Sales | 2.0x | 3.0x | 3.3x | |
Upside (Analyst Target) | 1.7% | 11.8% | 49.0% | |
Fair Value Upside | Unlock | 18.3% | 7.7% | Unlock |